Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.59 USD | -6.27% | +0.56% | -47.64% |
May. 28 | Earnings Flash (EVAX) EVAXION BIOTECH Reports Q1 Revenue $51,000 | MT |
May. 28 | Evaxion Biotech A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 6.27M | Sales 2025 * | 18.26M | Capitalization | 20.72M |
---|---|---|---|---|---|
Net income 2024 * | -11M | Net income 2025 * | -3M | EV / Sales 2024 * | 3.31 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.14 x |
P/E ratio 2024 * |
-2.76
x | P/E ratio 2025 * |
-1.94
x | Employees | 49 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.4% |
Latest transcript on Evaxion Biotech A/S
1 day | -5.20% | ||
1 week | +7.28% | ||
Current month | -8.15% | ||
1 month | -8.37% | ||
3 months | +4.64% | ||
6 months | -51.65% | ||
Current year | -44.14% |
Managers | Title | Age | Since |
---|---|---|---|
Andreas Mattsson
FOU | Founder | - | 08-08-10 |
Niels Møller
FOU | Founder | 46 | 08-08-10 |
Chief Executive Officer | 52 | 23-08-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 54 | 17-12-31 | |
Lars Holtug
BRD | Director/Board Member | 66 | 21-05-24 |
Marianne Søgaard
CHM | Chairman | 56 | 17-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-29 | 3.59 | -6.27% | 14 424 |
24-05-28 | 3.83 | -5.20% | 24,404 |
24-05-24 | 4.04 | +4.12% | 29,343 |
24-05-23 | 3.88 | +1.84% | 18,728 |
24-05-22 | 3.81 | +6.72% | 25,995 |
Delayed Quote Nasdaq, May 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.14% | 20.72M | |
+54.05% | 58.71B | |
-2.02% | 41.31B | |
+37.57% | 39.2B | |
-10.22% | 27.4B | |
+13.42% | 26.55B | |
-21.60% | 18.98B | |
+2.89% | 12.51B | |
+22.40% | 11.94B | |
+27.49% | 12.08B |
- Stock Market
- Equities
- EVAX Stock